Decision not to fund Cystic Fibrosis drug 'heartbreaking'

A leading Cystic Fibrosis campaigner has described the decision to deny funding for a groundbreaking drug as "heartbreaking".

The National Centre for Pharmaeconomics (NCPE) said that it recognises that Orkambi is effective - but the cost is too high.